Cargando…

Statin Exposure and Risk of Heart Failure After Anthracycline‐ or Trastuzumab‐Based Chemotherapy for Early Breast Cancer: A Propensity Score‒Matched Cohort Study

BACKGROUND: Statins are hypothesized to reduce the risk of cardiotoxicity associated with anthracyclines and trastuzumab. Our aim was to study the association of statin exposure with hospitalization or emergency department visits (hospital presentations) for heart failure (HF) after anthracycline‐ a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdel‐Qadir, Husam, Bobrowski, David, Zhou, Limei, Austin, Peter C., Calvillo‐Argüelles, Oscar, Amir, Eitan, Lee, Douglas S., Thavendiranathan, Paaladinesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955306/ https://www.ncbi.nlm.nih.gov/pubmed/33401953 http://dx.doi.org/10.1161/JAHA.119.018393

Ejemplares similares

Characteristics and Outcomes of Women Developing Heart Failure After Early Stage Breast Cancer Chemotherapy: A Population-Based Matched Cohort Study
por: Abdel-Qadir, Husam, et al.
Publicado: (2021)

Evaluation of Risk Prediction Models to Identify Cancer Therapeutics Related Cardiac Dysfunction in Women with HER2+ Breast Cancer
por: Suntheralingam, Sivisan, et al.
Publicado: (2022)

Modified Routine Cardiac Imaging Surveillance of Adult Cancer Patients and Survivors During the COVID-19 Pandemic
por: Calvillo-Argüelles, Oscar, et al.
Publicado: (2020)

Association of Early-Stage Breast Cancer and Subsequent Chemotherapy With Risk of Atrial Fibrillation
por: Abdel-Qadir, Husam, et al.
Publicado: (2019)

Regional myocardial edema detected by T2 mapping is a feature of cardiotoxicity in breast cancer patients receiving sequential therapy with anthracyclines and trastuzumab
por: Thavendiranathan, Paaladinesh, et al.
Publicado: (2014)

The Risk of Heart Failure and Other Cardiovascular Hospitalizations After Early Stage Breast Cancer: A Matched Cohort Study
por: Abdel-Qadir, Husam, et al.
Publicado: (2019)

The Association of Sodium-Glucose Cotransporter 2 Inhibitors With Cardiovascular Outcomes in Anthracycline-Treated Patients With Cancer
por: Abdel-Qadir, Husam, et al.
Publicado: (2023)

Deescalating Adjuvant Trastuzumab in HER2-Positive Early-Stage Breast Cancer: A Systemic Review and Meta-Analysis
por: Goldvaser, Hadar, et al.
Publicado: (2019)

Cardiovascular Disease Among Patients With AML and CHIP-Related Mutations
por: Calvillo-Argüelles, Oscar, et al.
Publicado: (2022)

Metformin to Prevent Anthracycline Cardiotoxicity?: That Would Be Sweet!
por: El-Rayes, Malak, et al.
Publicado: (2023)

Role of Oxidative Stress in the Mechanisms of Anthracycline-Induced Cardiotoxicity: Effects of Preventive Strategies
por: Carrasco, Rodrigo, et al.
Publicado: (2021)

Cardiac MRI and Clinical Follow-up in COVID-19 Vaccine–associated Myocarditis
por: Fronza, Matteo, et al.
Publicado: (2022)

Statins to mitigate cardiotoxicity in cancer patients treated with anthracyclines and/or trastuzumab: a systematic review and meta-analysis
por: Obasi, Mary, et al.
Publicado: (2021)

Immune checkpoint inhibitor-related myocarditis: an illustrative case series of applying the updated Cardiovascular Magnetic Resonance Lake Louise Criteria
por: Wintersperger, Bernd J, et al.
Publicado: (2022)

Immune Checkpoint Inhibitor-Associated Myocarditis With Persistent Troponin Elevation Despite Abatacept and Prolonged Immunosuppression
por: Liu, Shiying, et al.
Publicado: (2020)

Additional effect of anthracycline in preoperative chemotherapy with a sequential anthracycline‑containing regimen preceded by pertuzumab, trastuzumab and docetaxel combination therapy
por: Shima, Hiroaki, et al.
Publicado: (2022)

Clinical, Echocardiographic, and Biomarker Associations With Impaired Cardiorespiratory Fitness Early After HER2-Targeted Breast Cancer Therapy
por: Bonsignore, Alis, et al.
Publicado: (2021)

Self-Reported Physical Activity, QoL, Cardiac Function, and Cardiorespiratory Fitness in Women With HER2+ Breast Cancer
por: Peck, Serena S., et al.
Publicado: (2022)

The Predictive Value of Serum HER2/neu for Response to Anthracycline-Based and Trastuzumab-Based Neoadjuvant Chemotherapy
por: Lee, Jung Sun, et al.
Publicado: (2012)

Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation
por: Dieci, Maria Vittoria, et al.
Publicado: (2022)

Quantification of Extracellular Volume in CT in Neoadjuvant Chemotherapy in Breast Cancer: New Frontiers in Assessing the Cardiotoxicity of Anthracyclines and Trastuzumab
por: Chiocchi, Marcello, et al.
Publicado: (2023)

Acute Effects of Ibrutinib on Ventricular Arrhythmia in Spontaneously Hypertensive Rats
por: Du, Beibei, et al.
Publicado: (2020)

Research Quality and Impact of Cardiac Rehabilitation in Cancer Survivors: A Systematic Review and Meta-Analysis
por: Fakhraei, Reza, et al.
Publicado: (2022)

Anthracycline Chemotherapy and Cardiotoxicity
por: McGowan, John V, et al.
Publicado: (2017)

Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review
por: Porta‐Sánchez, Andreu, et al.
Publicado: (2017)

Statins in anthracycline-induced cardiotoxicity: Rac and Rho, and the heartbreakers
por: Henninger, Christian, et al.
Publicado: (2017)

Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation
por: Dieci, Maria Vittoria, et al.
Publicado: (2022)

Advances in anthracycline chemotherapy : epirubicin /
Publicado: (1984)

Comparison of Renal Effects of Ezetimibe–Statin Combination versus Statin Monotherapy: A Propensity-Score-Matched Analysis
por: Bae, Jaehyun, et al.
Publicado: (2020)

Statins increase the risk of herpes zoster: A propensity score-matched analysis
por: Kim, Min-Chul, et al.
Publicado: (2018)

A New Risk Factor for Cardiovascular Events in Patients Receiving Immune Checkpoint Inhibitor Therapy?
por: Thavendiranathan, Paaladinesh, et al.
Publicado: (2022)

Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer
por: Arciniegas Calle, Maria C., et al.
Publicado: (2018)

Arterial Stiffness in Breast Cancer Patients Treated with Anthracycline and Trastuzumab-Based Regimens
por: Yersal, Özlem, et al.
Publicado: (2018)

Structural and Electrophysiological Changes in a Model of Cardiotoxicity Induced by Anthracycline Combined With Trastuzumab
por: Altomare, Claudia, et al.
Publicado: (2021)

Importance of Considering Competing Risks in Time-to-Event Analyses: Application to Stroke Risk in a Retrospective Cohort Study of Elderly Patients With Atrial Fibrillation
por: Abdel-Qadir, Husam, et al.
Publicado: (2018)

Propensity‐matched analysis of the influence of perioperative statin therapy on outcomes after liver resection
por: Dasari, B. V. M., et al.
Publicado: (2019)

773. Statins Decrease the Risk of Active Tuberculosis: A Propensity Score-Matched Analysis
por: Kim, Min-Chul, et al.
Publicado: (2018)

Cardioprotective Effect of Dexrazoxane in Patients with HER2-Positive Breast Cancer Who Receive Anthracycline Based Adjuvant Chemotherapy Followed by Trastuzumab
por: Kim, In-Ho, et al.
Publicado: (2017)

Myocardial Inflammation at FDG PET/MRI and Clinical Outcomes in Symptomatic and Asymptomatic Participants after COVID-19 Vaccination
por: Marschner, Constantin Arndt, et al.
Publicado: (2023)

Pharmacodynamic modeling of cardiac biomarkers in breast cancer patients treated with anthracycline and trastuzumab regimens
por: de Vries Schultink, Aurelia H. M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_oa63ounlmgg8jg5tr8g2cti8bt